Claudin upregulation in ovarian carcinoma effusions is associated with poor survival

Human Pathology

Volumn 39, Issue 5, 2008, Pages 747-757

  Kleinberg, Lilach ^a   Holth, Arild ^a   Trope, Claes G ^a,c   Reich, Reuven ^b,d   Davidson, Ben ^a,c  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c UNIVERSITY OF OSLO   (Norway)

^d HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Claudins; Ovarian carcinoma; Serous effusions; Survival; Tumor progression

Indexed keywords

CADHERIN; CARBOPLATIN; CLAUDIN 1; CLAUDIN 3; CLAUDIN 4; CLAUDIN 7; EPIRUBICIN; INTEGRIN; MITOXANTRONE; PACLITAXEL; TAMOXIFEN CITRATE;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; EFFUSION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; METASTASIS; OVARY CANCER; OVERALL SURVIVAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SOLID TUMOR;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MEMBRANE PROTEINS; MIDDLE AGED; OVARIAN NEOPLASMS; PROGNOSIS; SURVIVAL ANALYSIS; UP-REGULATION;

EID: 42949113594     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2007.10.002     Document Type: Article

References (38)

1. Tsukita S., Furuse M., and Itoh M. Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2 (2001) 285-293
2. González-Mariscal L., Betanzos A., Nava P., and Jaramillo B.E. Tight junction proteins. Prog Biophys Mol Biol 81 (2003) 1-44
3. Van Itallie C.M., and Anderson J.M. Claudins and epithelial paracellular transport. Annu Rev Physiol 68 (2006) 403-429
4. Furuse M., Sasaki H., Fujimoto K., and Tsukita S. A single gene product, claudin-1 or -2, reconstitutes tight junction strands and recruits occluding in fibroblasts. J Cell Biol 143 (1998) 391-401
5. Morita K., Furuse M., Fujimoto K., and Tsukita S. Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands. Proc Natl Acad Sci U S A 96 (1999) 511-516
6. Yamauchi K., Rai T., Kobayashi K., Sohara E., et al. Disease-causing mutant WNK4 increases paracellular chloride permeability and phosphorylates claudins. Proc Natl Acad Sci U S A 101 (2004) 4690-4694
7. D'Souza T., Agarwal R., and Morin P.J. Phosphorylation of claudin-3 at threonine 192 by cAMP-dependent protein kinase regulates tight junction barrier function in ovarian cancer cells. J Biol Chem 280 (2005) 26233-26240
8. Hewitt K.J., Agarwal R., and Morin P.J. The claudin gene family: expression in normal and neoplastic tissues. BMC Cancer 6 (2006) 186
9. Morin P.J. Claudin proteins in human cancer: promising new targets for diagnosis and therapy. Cancer Res 65 (2005) 9603-9606
10. Swisshelm K., Macek R., and Kubbies M. Role of claudins in tumorigenesis. Adv Drug Deliv Rev 57 (2005) 919-928
11. Lu K.H., Patterson A.P., Wang L., et al. Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis. Clin Cancer Res 10 (2004) 3291-3300
12. Santin A.D., Zhan F., Bellone S., et al. Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy. Int J Cancer 112 (2004) 14-25
13. Bignotti E., Tassi R.A., Calza S., et al. Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy. Gynecol Oncol 103 (2006) 405-416
14. Hough C.D., Sherman-Baust C.A., Pizer E.S., et al. Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer. Cancer Res 60 (2000) 6281-6287
15. Hibbs K., Skubitz K.M., Pambuccian S.E., et al. Differential gene expression in ovarian carcinoma: identification of potential biomarkers. Am J Pathol 165 (2004) 397-414
16. Zhu Y., Brannstrom M., Janson P.O., and Sundfeldt K. Differences in expression patterns of the tight junction proteins, claudin 1, 3, 4 and 5, in human ovarian surface epithelium as compared to epithelia in inclusion cysts and epithelial ovarian tumours. Int J Cancer 118 (2006) 1884-1891
17. Rangel L.B., Agarwal R., D'Souza T., et al. Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas. Clin Cancer Res 9 (2003) 2567-2575
18. Heinzelmann-Schwarz V.A., Gardiner-Garden M., Henshall S.M., et al. Overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer. Clin Cancer Res 10 (2004) 4427-4436
19. Soini Y., and Talvensaari-Mattila A. Expression of claudins 1, 4, 5, and 7 in ovarian tumors of diverse types. Int J Gynecol Pathol 25 (2006) 330-335
20. Davidson B., Zhang Z., Kleinberg L., et al. Gene expression signatures differentiate ovarian/peritoneal serous carcinoma from diffuse malignant peritoneal mesothelioma. Clin Cancer Res 12 (2006) 5944-5950
21. Kleinberg L., Holth A., Fridman E., Schwartz I., Shih I.M., and Davidson B. The diagnostic role of claudins in serous effusions. Am J Clin Pathol 127 (2007) 928-937
22. Martinez-Estrada O.M., Culleres A., Soriano F.X., et al. The transcription factors Slug and Snail act as repressors of Claudin-1 expression in epithelial cells. Biochem J 394 (2006) 449-457
23. Elloul S., Bukholt Elstrand M., Nesland J.M., et al. Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma. Cancer 103 (2005) 1631-1643
24. Honda H., Pazin M.J., Ji H., Wernyj R.P., and Morin P.J. Crucial roles of Sp1 and epigenetic modifications in the regulation of the CLDN4 promoter in ovarian cancer cells. J Biol Chem 281 (2006) 21433-21444
25. Davidson B., Nielsen S., Christensen J., et al. The role of desmin and N-cadherin in effusion cytology: a comparative study using established markers of mesothelial and epithelial cells. Am J Surg Pathol 25 (2001) 1405-1412
26. Elloul S., Silins I., Trope C.G., Benshushan A., Davidson B., and Reich R. Expression of E-cadherin transcriptional regulators in ovarian carcinoma. Virchows Arch 449 (2006) 520-528
27. Oku N., Sasabe E., Ueta E., Yamamoto T., and Osaki T. Tight junction protein claudin-1 enhances the invasive activity of oral squamous cell carcinoma cells by promoting cleavage of laminin-5 gamma2 chain via matrix metalloproteinase (MMP)-2 and membrane-type MMP-1. Cancer Res 66 (2006) 5251-5257
28. Agarwal R., D'Souza T., and Morin P.J. Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity. Cancer Res 65 (2005) 7378-7385
29. Davidson B., Berner A., Nesland J.M., et al. E-cadherin and α-, β- and γ-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions. J Pathol 192 (2000) 460-469
30. Davidson B., Goldberg I., Reich R., et al. The αv and β1 integrin subunits are commonly expressed in malignant effusions from ovarian carcinoma patients. Gynecol Oncol 90 (2003) 248-257
31. Berner H.S., Davidson B., Berner A., et al. Expression of CD44 in effusions of patients diagnosed with serous ovarian carcinoma- diagnostic and prognostic implications. Clin Exp Metastasis 18 (2000) 197-202
32. Strobel T., and Cannistra S.A. Beta1-integrins partly mediate binding of ovarian cancer cells to peritoneal mesothelium in vitro. Gynecol Oncol 73 (1999) 362-367
33. Davidson B., Espina V., Flørenes V.A., et al. Proteomic profiling of malignant ovarian cancer effusions: survival and injury pathways discriminate clinical outcome. Clin Cancer Res 12 (2006) 791-799
34. Resnick M.B., Konkin T., Routhier J., Sabo E., and Pricolo V.E. Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study. Mod Pathol 18 (2005) 511-518
35. Cheung S.T., Leung K.L., Ip Y.C., et al. Claudin-10 expression level is associated with recurrence of primary hepatocellular carcinoma. Clin Cancer Res 11 (2005) 551-556
36. Resnick M.B., Gavilanez M., Newton E., et al. Claudin expression in gastric adenocarcinomas: a tissue microarray study with prognostic correlation. Hum Pathol 36 (2005) 886-892
37. Sanada Y., Oue N., Mitani Y., Yoshida K., Nakayama H., and Yasui W. Down-regulation of the claudin-18 gene, identified through serial analysis of gene expression data analysis, in gastric cancer with an intestinal phenotype. J Pathol 208 (2006) 633-642
38. Sheehan G.M., Kallakury B.V., Sheehan C.E., Fisher H.A., Kaufman Jr. R.P., and Ross J.S. Loss of claudins-1 and -7 and expression of claudins-3 and -4 correlate with prognostic variables in prostatic adenocarcinomas. Hum Pathol 38 (2007) 564-569